Free Trial
OTCMKTS:ABMC

American Bio Medica (ABMC) Stock Price, News & Analysis

American Bio Medica logo

About American Bio Medica Stock (OTCMKTS:ABMC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ABMC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for American Bio Medica and its competitors with MarketBeat's FREE daily newsletter.

ABMC Stock News Headlines

American Bio Medica Corp
American Bio Medica Corp.
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
American Bio Medica Corporation (ABMC)
Specimen Validity Testing Market Research, 2023-2030
ABMC American Bio Medica Corporation
See More Headlines

ABMC Stock Analysis - Frequently Asked Questions

American Bio Medica Corp. (OTCMKTS:ABMC) announced its earnings results on Monday, May, 14th. The company reported ($0.01) EPS for the quarter. The business had revenue of $1.04 million for the quarter.

Shares of ABMC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that American Bio Medica investors own include FuelCell Energy (FCEL), OPKO Health (OPK), Canadian Western Bank (CWB), Canopy Growth (CGC), Newmont (NEM), Cortex Pharmaceuticals (RSPI) and V Group (VGID).

Company Calendar

Last Earnings
5/14/2018
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:ABMC
CIK
896747
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$910 thousand
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
-2.17
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:ABMC) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners